SLC5A2 and type 1 diabetes mellitus: This review provides a comprehensive overview of not only the safety and efficacy of SGLT2 inhibitors by including randomized control studies but also observational studies showing the benefits and risks of SGT2 inhibitors in type 1 diabetes.